Professor of Medicine, University Cincinnati
Rheumatology
Dr. Michael E. Luggen, MD
|
|
Give Review
Dr. Michael E. Luggen is an expert in the field of Rheumatology. He went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He has 5 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Fellow", "Top MD" and "Fellow (FACR)". Doctor Michael E. Luggen, MD is a published physician. He has 37 publications published. The most current publication "Seropositive, symmetric polyarthritis in a patient with poorly differentiated lung carcinoma: carcinomatous polyarthritis, hypertrophic osteoarthropathy, or rheumatoid..." Michael E. Luggen accepts Medicare payments and is listed with Medicare.gov.
Publications
- Non-criteria anti-phospholipid antibodies and cognitive impairment in SLE.
- Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus: A Controlled Study.
- Hydroxychloroquine and risk of diabetes in patients with rheumatoid Arthritis.
- Concomitant leflunomide therapy in patients with active rheumatoid Arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
- T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune Diseases and transplantation.
- Hypertrophic pachymeningitis in rheumatoid Arthritis after adalimumab administration.
- Selective costimulation modulation using abatacept in patients with active rheumatoid Arthritis while receiving etanercept: a randomised clinical trial.
- Abatacept for rheumatoid Arthritis refractory to tumor necrosis factor alpha inhibition.
- Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid Arthritis failing MTX monotherapy: open-label extension of a randomized, dou...
- Monitoring methotrexate toxicity in juvenile idiopathic Arthritis.
- Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid Arthritis and an inadequate response...
- Cognitive dysfunction in SLE: development of a screening tool.
- Seropositive, symmetric polyArthritis in a patient with poorly differentiated lung carcinoma: carcinomatous polyArthritis, hypertrophic osteoarthropathy, or rheumatoid...
- Costimulatory blockade in patients with rheumatoid Arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eig...
- Treatment of rheumatic Diseases in the elderly.
- The evolution of Raynaud''s phenomenon: a longterm prospective study.
- Early undifferentiated connective tissue Disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue Diseases comp...
- Early undifferentiated connective tissue Disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).
- [Duration of use of non-steroidal anti-inflammatory agents in patients with rheumatoid Arthritis].
- A computer model of the renal countercurrent system.
- Skin effects of occupational Kneeling.
- Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid Arthritis. A controlled clinical trial.
- Lack of association between HLA-DR2 and clinical response to methotrexate in patients with rheumatoid Arthritis.
- Morbidity from repetitive Knee trauma in carpet and floor layers.
- Unusual longevity in primary systemic amyloidosis: a 19-year survivor.
- A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid Arthritis.
- Nonsteroidal antiinflammatory drugs in rheumatoid Arthritis: duration of use as a measure of relative value.
- Remodeling the pyramid--a concept whose time has not yet come.
- Prenatal screening for anticardiolipin antibody.
- Early undifferentiated connective tissue Disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic Diseases.
- Early undifferentiated connective tissue Disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue Diseases compar...
- A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid Arthritis.
- Early undifferentiated connective tissue Disease (CTD). VI. An inception cohort after 10 years: Disease remissions and changes in diagnoses in well established and und...
- Early undifferentiated connective tissue Disease. V. An inception cohort 5 years later: Disease remissions and changes in diagnoses in well established and undifferent...
- Comparison of sulfasalazine and placebo in the treatment of psoriatic Arthritis. A Department of Veterans Affairs Cooperative Study.
- Comparison of sulfasalazine and placebo in the treatment of Ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.
Schools
Columbia University College Of Physicians and Surgeons
Cincinnati Genl Hospital
University Cincinnati
Procedures Preformed
- Joint Drainage
- Steroid Injection
Conditions Treated
- Adhesive Capsulitis
- Ankylosing Spondylitis
- Antiphospholipid Syndrome (APS)
- Arthritis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow
- Top MD
- Fellow (FACR)
Education
-
University Hospital - University of Cincinnati College of Medicine -
Columbia University College of Physicians & Surgeons
Hospital
-
Christ Hospital -
University of Cincinnati Medical Center
Drug Facts
| NPI NUMBER | 1386635431 | |
| NPPES Provider LastName | LUGGEN | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 452191018 | |
| NPPES Provider State | OH | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 3896.0 | |
| Distinct Opioid Count | 9.0 | |
| Opioid Claim Count | 648.0 | |
| Percent Opioid Claims | 16.63 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386635431 |
| Last Name Of The Provider | LUGGEN |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Robert E. Hiltz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paige A. De Buys, MD |
|
|
Dr. John L. Houk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Surabhi Agarwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mahnaz Saoudian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine L. Chhakchhuak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amber Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Delorenzo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne B. Mongey, MD
This Doctor is OpenDoctor Recommended.
|